Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: CAR-T Cells for HIV Infection [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial is evaluating CAR-T cell therapy for HIV infection and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CAR-T cell therapy

Snippet

Sponsor: Steven Deeks | Conditions: HIV Infections | Phase 1, Phase 2 | Status: RECRUITING